Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma

Cancer Cell (2006) 9:405-416. Published: 2006.05.15

Richard Smith, Leah A. Owen, Deborah J. Trem, Jenny S. Wong, Jennifer S. Whangbo, Todd R. Golub, and Stephen L. Lessnick

Read Manuscript


Our understanding of Ewing's sarcoma development mediated by the EWS/FLI fusion protein has been limited by a lack of knowledge regarding the tumor cell of origin. To circumvent this, we analyzed the function of EWS/FLI in Ewing's sarcoma itself. By combining retroviral-mediated RNA interference with reexpression studies, we show that ongoing EWS/FLI expression is required for the tumorigenic phenotype of Ewing's sarcoma. We used this system to define the full complement of EWS/FLI-regulated genes in Ewing's sarcoma. Functional analysis revealed that NKX2.2 is an EWS/FLI-regulated gene that is necessary for oncogenic transformation in this tumor. Thus, we developed a highly validated transcriptional profile for the EWS/FLI fusion protein and identified a critical target gene in Ewing's sarcoma development.


Supplemental Data

Description Link/Filename
Manuscript Smith et al.pdf
Preview article Cancer Cell preview.pdf
CEL file descriptions Smith_et_al_CEL_file_list.xls
CEL files for knockdown samples
CEL files for inducible samples
Supplemental appendix 1 Smith, et al., supplemental appendix 1.doc
Supplemental appendix 2 Smith, et al., supplemental appendix 2.xls
Supplemental appendix 3 Smith, et al., supplemental appendix 3.xls